Sex Differences in the Clinical Features and Outcomes of Patients with Acute Coronary Syndrome Treated with Two Generations (Absorb and Magmaris) of Bioresorbable Vascular Scaffolds
- PMID: 34501216
- PMCID: PMC8432059
- DOI: 10.3390/jcm10173768
Sex Differences in the Clinical Features and Outcomes of Patients with Acute Coronary Syndrome Treated with Two Generations (Absorb and Magmaris) of Bioresorbable Vascular Scaffolds
Abstract
Background: Despite the developments in percutaneous coronary interventions (PCI), women are still more likely than men to have unfavorable outcomes after PCI performed in Acute Coronary Syndrome (ACS). The mechanisms of this phenomena are not fully understood. Potential benefits of bioresorbable scaffolds (BRS) may be particularly expressed in the female population. Nevertheless, the data available currently are inconsistent and limited. This study evaluated the gender-related differences in the short-term clinical outcomes in ACS patients treated with implantation of two generations of BRS (first generation, Absorb; second generation, Magmaris).
Methods: The study was divided into two arms. To the first one, we qualified 160 patients with ACS treated with PCI who received 210 Absorb scaffolds. The second arm was composed of 193 patients with ACS who underwent PCI with Magmaris implantation.
Results: There were no significant sex-related differences in primary endpoints (cardiovascular-death, myocardial infarction, in-stent thrombosis) or principal secondary endpoints (of target-lesion failure, scaffold restenosis, death from any reason, other cardiovascular events) in either generation of BRS in a 1-year follow-up.
Conclusions: Both genders tended to have a similar outcome in routine clinical practice following BRS implantation due to ACS. The magnesium bioresorbable scaffold (Magmaris) early outcome seemed to be more favorable in comparison to the Absorb scaffold.
Keywords: Absorb; Magmaris; acute coronary syndrome (ACS); bioresorbable scaffold (BRS); coronary artery disease (CAD); gender-related prognosis; percutaneous coronary intervention (PCI); sex differences.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Dudek D., Siudak Z., Grygier M., Araszkiewicz A., Dąbrowski M., Kusa J., Hawranek M., Huczek Z., Kralisz P., Roleder T., et al. Interventional cardiology in Poland in 2019. Summary report of the Association of Cardiovascular Interventions of the Polish Cardiac Society (AISN PTK) and Jagiellonian University Medical College. Adv. Interv. Cardiol. 2020;16:123–126. doi: 10.5114/aic.2020.96054. - DOI - PMC - PubMed
-
- O’Neil A., Scovelle A.J., Thomas E., Russell J.D., Taylor C.B., Hare D.L., Toukhsati S., Oldroyd J., Rangani W.T., Dheerasinghe D.A.F., et al. Sex-Specific Differences in Percutaneous Coronary Intervention Outcomes After a Cardiac Event: A Cohort Study Examining the Role of Depression, Worry and Autonomic Function. Heart Lung Circ. 2020;29:1449–1458. doi: 10.1016/j.hlc.2020.03.001. - DOI - PubMed
-
- Nagumo S., Mori H., Maeda A., Akashi Y.J., Ako J., Ikari Y., Ebina T., Sato N., Tamura K., Namiki A., et al. Sex-Related Differences in In-Hospital Mortality in Japanese ST-Elevation Acute Myocardial Infarction Patients Presenting to Hospital in the 24 Hours After Symptom Onset―Results From K-ACTIVE―. Circ. Rep. 2019;1:313–319. doi: 10.1253/circrep.CR-19-0041. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
